401622-26-2

Basic information

• Product Name: Benzoic acid, 2-(carboxymethoxy)-4-chloro-
• CAS NO: 401622-26-2
• Molecular Formula: C9H7ClO5
• Molecular Weight: 230.605
• Mol File: 401622-26-2.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2-(carboxymethoxy)-4-chloro-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-(carboxymethoxy)-4-chloro-(401622-26-2)
• EPA Substance Registry System: Benzoic acid, 2-(carboxymethoxy)-4-chloro-(401622-26-2)

Safety Data

• Hazardous Substances Data: 401622-26-2(Hazardous Substances Data)

Upstream product

• 5106-98-9 4-chlorosalicylic acid 
• 22717-55-1 methyl 4-chloro-2-hydroxybenzoate 
• 960063-83-6 C₁₃H₁₅ClO₅ 
• 796851-66-6 methyl 4-chloro-2-(2-ethoxy-2-oxoethoxy)benzoate 

Downstream Products

• 3260-78-4 6-chlorobenzofuran-3(2H)-one 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK

Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.

BENZOFURANYL- AND BENZOTHIENYL- PIPERAZINYL QUINOLINES AND METHODS OF THEIR USE

Benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives and compositions containing such compounds are disclosed. Methods of using benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives and compositions containing such composition in the treatment and/or prevention of serotonin-related disorders, such as depression and anxiety, are also disclosed. In addition, processes for the preparation of benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives are disclosed.

Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use

3-Piperidin-4-yl-1H-indole and 3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indole derivatives are disclosed. Methods of using the derivatives and compositions containing the derivatives in the prevention and/or treatment of serotonin disorders, such as depression and anxiety, are also disclosed. Additionally, processes for the preparation of 3-piperidin-4-yl-1H-indole and 3-(1,2,3,6-tetrahydro-pyridin-4-yl)-1H-indole derivatives are disclosed.